Patients on immunosuppressive drugs have been excluded from COVID-19 vaccines trials, creating concerns regarding their efficacy.
-
2022 (v1)PublicationUploaded on: February 14, 2024
-
2021 (v1)Publication
Background: Few data exist regarding the long-term effectiveness of golimumab in ulcerative colitis. No data have been reported on real-world continuous clinical response.Objective: This study aimed to describe the long-term outcomes in a large cohort of patients on golimumab who had ulcerative colitis.Methods: Consecutive patients with active...
Uploaded on: February 14, 2024 -
2022 (v1)Publication
Background Anemia is a common extraintestinal manifestation of inflammatory bowel disease (IBD), with a 6% to 74% prevalence and a negative impact on patient survival and quality of life, although the prevalence is apparently declining due to improved disease treatment. We aimed to investigate the prevalence, pathogenesis, and clinical...
Uploaded on: February 4, 2024 -
2020 (v1)Publication
No description
Uploaded on: April 14, 2023